LECT2 and liver cancer: CHM2 suppresses angiogenesis by blocking VEGF165-VEGFR2 signaling in liver cancer (5) and reduces endothelial cell migration and tube formations by activating LECT2-Tie1 signaling in liver fibrosis (6).